Use of dexmedetomidine in patients with trisomy 21 after cardiac surgery

被引：11
|
作者：
Kalyanaraman, M. [1 ]
Costello, J. L. [1 ]
Starr, J. P. [1 ]
机构：
[1] Childrens Hosp New Jersey, Newark, NJ 07112 USA
来源：
PEDIATRIC CARDIOLOGY | 2007年 / 28卷 / 05期
关键词：
dexmedetomidine; cardiac Surgery; postoperative; trisomy; 21; sedation; analgesia;
D O I：
10.1007/s00246-006-0072-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Children with trisomy 21 have a high incidence of congenital heart disease that frequently requires surgical repair. These patients often require multiple and higher dosage sedatives during the postoperative period. Dexmedetomidine is an alpha(2)-adrenergic receptor agonist that has sedative, analgesic, and anxiolytic properties. We report the successful use of dexmedetomidine in patients with trisomy 21 following surgical repair of congenital heart disease.
引用
收藏
页码：396 / 399
页数：4
相关论文
共 50 条
  • [1] Use of Dexmedetomidine in Patients with Trisomy 21 After Cardiac Surgery
    M. Kalyanaraman
    J. L. Costello
    J. P. Starr
    Pediatric Cardiology, 2007, 28 : 396 - 399
  • [2] Dexmedetomidine is Associated with an Increased Incidence of Bradycardia in Patients with Trisomy 21 After Surgery for Congenital Heart Disease
    Ueno, Kentaro
    Ninomiya, Yumiko
    Shiokawa, Naohiro
    Hazeki, Daisuke
    Eguchi, Taisuke
    Kawano, Yoshifumi
    PEDIATRIC CARDIOLOGY, 2016, 37 (07) : 1228 - 1234
  • [3] Use of dexmedetomidine in children after cardiac and thoracic surgery
    Chrysostomou, Constantinos
    Di Filippo, Sylvie
    Manrique, Ana-Maria
    Schmitt, Carol G.
    Orr, Richard A.
    Casta, Alfonso
    Suchoza, Erin
    Janosky, Janine
    Davis, Peter J.
    Munoz, Ricardo
    PEDIATRIC CRITICAL CARE MEDICINE, 2006, 7 (02) : 126 - 131
  • [4] Dexmedetomidine use in a pediatric cardiac intensive care unit: Can we use it in infants after cardiac surgery?
    Chrysostomou, Constantinos
    De Toledo, Joan Sanchez
    Avolio, Tracy
    Motoa, Maria V.
    Berry, Donald
    Morell, Victor O.
    Orr, Richard
    Munoz, Ricardo
    PEDIATRIC CRITICAL CARE MEDICINE, 2009, 10 (06) : 654 - 660
  • [5] Dexmedetomidine utilisation and outcomes of children with trisomy 21 undergoing congenital heart disease surgery
    Moffett, Brady S.
    Mossad, Emad B.
    Tobias, Joseph D.
    Cabrera, Antonio G.
    CARDIOLOGY IN THE YOUNG, 2015, 25 (05) : 958 - 962
  • [6] Dexmedetomidine is Associated with an Increased Incidence of Bradycardia in Patients with Trisomy 21 After Surgery for Congenital Heart Disease
    Kentaro Ueno
    Yumiko Ninomiya
    Naohiro Shiokawa
    Daisuke Hazeki
    Taisuke Eguchi
    Yoshifumi Kawano
    Pediatric Cardiology, 2016, 37 : 1228 - 1234
  • [7] Cardiac Surgery in Patients with Trisomy 18
    Kaneko, Yukihiro
    Kobayashi, Jotaro
    Achiwa, Ikuya
    Yoda, Hitoshi
    Tsuchiya, Keiji
    Nakajima, Yayohi
    Endo, Daiichi
    Sato, Hajime
    Kawakami, Tadashi
    PEDIATRIC CARDIOLOGY, 2009, 30 (06) : 729 - 734
  • [8] Effect of Dexmedetomidine on Cardiac Surgery Patients
    Xiao, Man
    Jiang, Chong-Fa
    Gao, Qin
    Pan, Jue
    Zhang, Hong
    Wu, Sheng-Nan
    Dou, Mao-Sen
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2023, 81 (02) : 104 - 113
  • [9] Dexmedetomidine sedation after cardiac surgery decreases atrial arrhythmias
    Turan, Alparslan
    Bashour, C. Allen
    You, Jing
    Kirkova, Yordanka
    Kurz, Andrea
    Sessler, Daniel I.
    Saager, Leif
    JOURNAL OF CLINICAL ANESTHESIA, 2014, 26 (08) : 634 - 642
  • [10] Outcomes of cardiac surgery in trisomy 18 patients
    Muneuchi, Jun
    Yamamoto, Junko
    Takahashi, Yasuhiko
    Watanabe, Mamie
    Yuge, Tetsuji
    Ohno, Takuro
    Imoto, Yutaka
    Sese, Akira
    Joo, Kunitaka
    CARDIOLOGY IN THE YOUNG, 2011, 21 (02) : 209 - 215
12345